Cleared Traditional

K103744 - DROPPER A1C DIABETES CONTROL

K103744 is an FDA 510(k) clearance for DROPPER A1C DIABETES CONTROL, manufactured by Quantimetrix Corp.. The device is a Class 1 Chemistry device with product code JJX cleared through the Traditional 510(k) pathway after a 140-day FDA review.

K103744 · Quantimetrix Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2011
Decision
140d
Days
Class 1
Risk

K103744 is an FDA 510(k) clearance for the DROPPER A1C DIABETES CONTROL. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Quantimetrix Corp. (Redondo Beach, US). The FDA issued a Cleared decision on May 12, 2011 after a review of 140 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Quantimetrix Corp. devices

FDA 510(k) Submission Details - K103744

510(k) Number K103744 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 2010
Decision Date May 12, 2011
Days to Decision 140 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d slower than avg
Panel avg: 88d · This submission: 140d
Pathway characteristics
Predicate-based equivalence.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 417
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K103744.
ELECSYS T3 CALCHECK 5
K111552 · Roche Diagnostics · Jul 2011
ELECSYS SHBG CALCHECK 5
K111349 · Roche Diagnostics · Jun 2011
FUJIREBIO DIAGNOSTICS VITAMIN D CONTROL
K110641 · Fujirebio Diagnostics,Inc. · May 2011
ELECSYS PROLACTIN II CALCHECK 5
K110613 · Roche Diagnostics · May 2011
IMMULITE/IMMULITE 1000 PROGESTERONE CALIBRATION VERIFICATION (CVM)
K103683 · Siemens Healthcare Diagnostics · Apr 2011
FDI GLUCOSE CONTROL SOLUTION FOR AVIVA
K110436 · Fujirebio Diagnostics,Inc. · Apr 2011